M. Hippius

发表

Magnetic Active Agent Release System (MAARS): evaluation of a new way for a reproducible, externally controlled drug release into the small intestine.

A. Stallmach, C. T. Dietzel, H. Richert, 2012, Journal of controlled release : official journal of the Controlled Release Society.

Influence of grapefruit juice on the pharmacokinetics of a slow release nifedipine formulation.

H. Sigusch, M. Hippius, L. Henschel, 1994, Die Pharmazie.

Pharmacokinetic interactions of nifedipine and quinidine.

H. Sigusch, E. Brendel, M. Hippius, 1995, Die Pharmazie.

Adverse drug reaction monitoring in Jena--experiences of a regionalized pharmacovigilance centre.

M. Hippius, T. Sicker, A. Hoffmann, 1998, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

Safety of Beta-Blockers Metabolised Via CYP2D6 is Sex-Dependent

M. Hippius, W. Siegmund, J. Szymański, 2006 .

Tolerability of β‐blockers metabolized via cytochrome P450 2D6 is sex‐dependent

J. Hasford, M. Hippius, W. Siegmund, 2006 .

Adverse drug reaction monitoring in Jena

M. Hippius, K. Farker, A. Hoffmann, 2003 .

Adverse drug reaction monitoring in Jena. Relevance of polymorphic drug metabolizing enzymes for inducing adverse drug reactions.

M. Hippius, K. Farker, A. Hoffmann, 2003, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

Adverse drug reaction monitoring--digitoxin overdosage in the elderly.

M. Hippius, J. Hasford, T. Sicker, 2001, International journal of clinical pharmacology and therapeutics.

Lack of pharmacokinetic interaction between dextromethorphan, coumarin and mephenytoin in man after simultaneous administration.

M. Hippius, U. Merkel, L. Henschel, 1996, Die Pharmazie.

In vitro investigations of drug release and penetration--enhancing effect of ultrasound on transmembrane transport of flufenamic acid.

M. Hippius, U. Smolenski, A. Hoffmann, 1998, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

Substituierte Pyrazolid‐3‐on‐azomethinimine

M. Hippius, G. Geissler, K. Angermüller, 2010 .

Analysis of German package inserts.

J Fuchs, M Hippius, M Schaefer, 2006, International journal of clinical pharmacology and therapeutics.

Self-Medication with Over-the-Counter and Prescribed Drugs Causing Adverse-Drug-Reaction-Related Hospital Admissions: Results of a Prospective, Long-Term Multi-Centre Study

J. Hasford, M. Hippius, K. Farker, 2014, Drug Safety.

Assessment of ADRs associated with lipid-lowering agents recorded in the Department of Internal Medicine, University Hospital, Jena.

M. Hippius, K. Farker, S. Helble, 2002, International journal of clinical pharmacology and therapeutics.

Inappropriate dosage instructions in package inserts.

Joerg Fuchs, Marion Hippius, M. Hippius, 2007, Patient education and counseling.

Can oral contraceptive steroids influence the elimination of nifedipine and its primary pryidine metabolite in humans?

M. Hippius, Á. Balogh, U. Mellinger, 1998, European Journal of Clinical Pharmacology.

Preventable ADRs leading to hospitalization — results of a long-term prospective safety study with 6,427 ADR cases focusing on elderly patients

M. Hippius, W. Siegmund, J. Szymański, 2018, Expert opinion on drug safety.

Bleeding complications and liver injuries during phenprocoumon treatment: a multicentre prospective observational study in internal medicine departments.

J. Hasford, M. Hippius, W. Siegmund, 2013, Deutsches Arzteblatt international.

Excessive medical information increase in package inserts.

M Hippius, J Fuchs, S Werner, 2010, International journal of clinical pharmacology and therapeutics.

[Rhabdomyolysis as a rare complication of theophylline poisoning].

M. Hippius, R. Pfeifer, A. Hoffmann, 2001, Medizinische Klinik.

[Adverse drug reactions and interactions - cause of admission to hospital and after discharge].

M. Hippius, 2011, Therapeutische Umschau. Revue therapeutique.

Tolerability of beta-blockers metabolized via cytochrome P450 2D6 is sex-dependent.

J. Hasford, M. Hippius, W. Siegmund, 2006, Clinical pharmacology and therapeutics.

First results from an intensified monitoring system to estimate drug related hospital admissions.

S. Schneeweiss, J. Hasford, W. Swoboda, 2001, British journal of clinical pharmacology.

Adverse drug reactions in Germany: direct costs of internal medicine hospitalizations

Marion Hippius, Joerg Hasford, Dominik Rottenkolber, 2011, Pharmacoepidemiology and drug safety.

M. Hippius, J. Hasford, A. Riethling, 2003 .

Phenotyping with sulfasalazine - time dependence and relation to NAT2 pharmacogenetics.

M. Hippius, B. Schug, H. Blume, 2010, International journal of clinical pharmacology and therapeutics.

Chronomodulated chemotherapy with oxaliplatin, 5-FU and sodium folinate in metastatic gastrointestinal cancer patients: original analysis of non-hematological toxicity and patient characteristics in a pilot investigation.

K. Höffken, M. Hippius, U. Wedding, 2006, International journal of clinical pharmacology and therapeutics.

New Font Size Requirements in Package Inserts of Medicines Advantages and disadvantages

M. Hippius, Tina Heyer, Diana Langenhan, 2010 .